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B-Hydroxyaspartic acid is a rare amino acid, present in all vitamin K-dependent plasma proteins except 
prothrombin, and is formed by a post-translational hydroxylation of aspartic acid. We have now 
investigated whether this hydroxylation, like that of proline in collagen, is vitamin C-dependent. The 
vitamin K-dependent plasma proteins were isolated from normal and scorbutic guinea pig plasma by 
barium citrate adsorption and the ,&hydroxyaspartic acid content was determined. Compared with normal 
animals, scorbutic animals showed no significant reduction of 8-hydroxyaspartic acid content. In 
warfarin-treated animals there was a decreased content of both &hydroxyaspartic acid and y- 
carboxyglutamic acid in the barium citrate adsorbed fraction. It was concluded that the post-translational 
hydroxylation of aspartic acid is unlikely to be vitamin C-dependent. 
Blood coagulation y-Carboxyglutamic acid 
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1. INTRODUCTION 
&Hydroxyaspartic acid is a rare amino acid 
recently shown to be present in several of the 
vitamin K-dependent plasma proteins [l-5]. 
Bovine protein C [1,3,4], bovine and human factor 
X [2,4,5], bovine and human factor IX [3,4,5], 
bovine factor VII [3] and bovine protein Z [4] all 
contain approx. 1 mol ,&hydroxyaspartic acid per 
mol protein, and protein S contains 2-3 mol fl- 
hydroxyaspartic acid per mol protein [4]. Pro- 
thrombin, however, the most abundant vitamin K- 
dependent plasma protein, lacks &hydroxyas- 
par-tic acid both in the cow and the human [3,4]. 
The y-carboxyglutamic acid-containing bone pro- 
tein, which is vitamin K-dependent, also lacks 
@-hydroxyaspartic acid [4]. Analysis of a number 
of common non-vitamin K-dependent proteins 
suggests that ,&hydroxyaspartic acid is confined to 
y-carboxyglutamic acid-containing proteins [4]. 
Bovine protein C has &hydroxyaspartic acid in 
position 71 of its light chain [l]. According to se- 
quence homology, 8-hydroxyaspartic acid oc- 
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Vitamin K Warfarin 
cupies a corresponding position in human [2] and 
bovine factor X [5], and in human [3] and bovine 
factor IX [3,5]. 
The nucleotide sequences coding for human fac- 
tor IX [6,7] and bovine factor IX [8] have been 
determined. They both have a triplet coding for 
aspartic acid at the position for the /3- 
hydroxyaspartic acid residue, proving that fi- 
hydroxyaspartic acid is formed by a post- 
translational hydroxylation of aspartic acid. Post- 
translational hydroxylation of proteins, e.g., for- 
mation of hydroxyproline and hydroxylysine in 
collagen, has long been known to depend on 
vitamin C. Lack of vitamin C causes scurvy with 
decreased formation of secreted collagen, which is 
thought to be due to an inadequate hydroxylation 
and consequent increased intracellular degradation 
of the newly synthesized procollagen polypeptide 
chains [9]. The resulting scarcity of extracellular 
collagen is regarded as a major cause of fragility in 
the connective tissue, and of the bleeding and im- 
paired wound healing in scorbutic individuals. 
Bleeding is one of the most prominent signs in 
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the adult scorbutic patient [lo], and several at- 
tempts have been made to demonstrate a defect in 
the hemostatic system [l I], but with questionable 
success [12]. The finding of a post-translationally 
hydroxylated amino acid in several of the coagula- 
tion factors, and the possibility that the hydroxyla- 
tion of this amino acid is vitamin C-dependent, 
suggest an attractive h~othesis for the explana- 
tion of the bleeding in scurvy: i.e., inadequate for- 
mation of ~-hydroxyaspartic acid in the coagula- 
tion factors results in a deficient hemostatic 
function. 
To test this hypothesis, proteins containing y- 
carboxyglut~i~ acid were isolated by barium 
citrate adsorption from the plasma of normal and 
scorbutic guinea pigs, and the ,&hydroxyaspartic 
acid content in the isolated fraction was deter- 
mined. Here we report the results of these experi- 
ments and the finding of normal amounts of 
~-hydroxy~p~ic acid in the barium citrate ad- 
sorbed fraction from scorbutic animals. In a con- 
trol experiment, guinea pigs treated with warfarin 
showed an expected decrease of the y-carboxy- 
glutamic acid content with a parallel decrease of P- 
hydroxyaspartic acid. 
2. MATERIALS AND METHODS 
Reid-Briggs guinea pig diet without ascorbic 
acid was obtained from USB (Cleveland, OH), 
ascorbic acid from Merck (Darmstadt), and 
sodium warfarin (Waran* ) from Nyegaard & Co. 
(Oslo). Karboxyglutamic acid was prepared as in 
1131. Bovine prothrombin fragment 1 was isolated 
from bovine prothrombin as in [14]. Immediately 
after 125I labeling by the lactoperoxid~e method 
[15], it was subjected to gel chromatography on a 
column (1.5 x 5 cm) of Sephadex G-25 (PD-10 col- 
umn, Pharmacia, Uppsala) at 20°C in 50 mM 
Tris-WC1 buffer (pH 7.4). Before use 1 ml of a 
solution of bovine serum albumin in the Tris buf- 
fer (1 g/l) was passed through the column. The 
specific activity of the labeled fragment 1 was ap- 
prox. 9.5 aCi/pg. It was kept in the 
chromatography buffer at - 20°C and used within 
34 days after labeling. 
2.1. Experimental scurvy 
Guinea pigs weighing 380-600 g were randomly 
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divided into two groups, both of which were fed 
only Reid-Briggs ascorbic acid-deficient diet and 
supplied with tap water ad libitum. For one group 
(control) the water contained ascorbic acid (1 g/l), 
while for the second group (experimental) no addi- 
tions were made to the water. The animals were 
weighed daily. At the end of the experiment, when 
scurvy had developed in the experimental group, 
blood was collected from both control and ex- 
perimental animals by cardiac puncture. The blood 
was drawn into Vacutainere test tubes (Becton 
Dickinson & Co., Orangeburg, NY), containing 
l/10 vol. of 0.13 M sodium citrate. The animals 
were then killed and dissected to reveal any hemor- 
rhage. The blood was centrifuged within an hour 
of collection and the plasma stored at - 70°C. 
2.2. Warfarin treatment 
Guinea pigs weighing ~~ g and kept on or- 
dinary guinea pig diet were each injected in- 
traperitoneally with sodium warfarin (1 mg/kg 
body wt) dissolved in 1 ml saline, control animals 
receiving saline only. Blood was collected 24 h 
later and plasma separated as described in section 
2.1. 
2.3. r~olat~on of proteins eon taining 
~-carboxyg~~tamic acid by b&urn citrate 
adsorption 
To 1 .O ml of titrated plasma was added 10 yl of 
a solution of 12sI-prothrombin fragment I (ap- 
prox. 0.1 yCi), and barium citrate was then 
precipitated in the sample by the addition of 80 yl 
of 1 M BaC12. After standing for 1 h at 2O’C the 
precipitate was sedimented by centrifugation at 
5000 x g for 5 min, and the supernatant discarded. 
The precipitate was washed twice by suspension in 
200 pl of 0.15 M NaCl, followed by centrifugation 
as above. 
The washed sediment was dissolved in 400 pl of 
0.2 M sodium EDTA (pH 7.4) and then dialyzed 
against 0.1 M NH4HC03 at 20°C for 24 h using 
Spectrapore membrane tubing no.3 (Spectrum 
Medical Industries Inc., Terminal Annex, Los 
Angeles, CA), After dialysis, recovery was 
estimated from the radioactivity remaining in the 
dialyzed sample. Radioactivity was measured in a 
Nuclear Electronics NE1600 gamma spectrometer. 
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2.4. Amino acid analysis 
Each dialyzed sample was divided into two por- 
tions: 4/5 of the sample was subjected to acid 
hydrolysis to measure ,&hydroxyaspartic acid and 
ordinary amino acids; l/5 of the sample was sub- 
jected to alkaline hydrolysis to determine the y- 
carboxyglutamic acid content. Prior to hydrolysis 
the samples were lyophilized in the hydrolysis tube. 
Acid hydrolysis, ordinary amino acid analysis and 
measurement of ,&hydroxyaspartic acid, were per- 
formed as in [4] for purified proteins. 
Alkaline hydrolysis was performed in 1OOpl of 
4 M LiOH at 110°C for 24 h in evacuated alkali- 
resistant glass tubes, with 10.4 nmol ,&- 
carboxyglutamic acid added as an internal stan- 
dard [13]. A standard containing 5.0 nmol y- 
carboxyglutamic acid and 10.4 nmol fl- 
carboxyglutamic acid was treated in the same way 
as the samples. The alkaline hydrolysates were 
neutralized and Li+ precipitated by adding 20 ~1 of 
6.67 M HJPO~. After centrifugation the super- 
natants were analyzed using the same 
chromatographic system as for P-hydroxyaspartic 
acid [4]. 
2.5. Activated partial thromboplastin time 
(APT-time) 
Commercial reagents were used (APTT, General 
Diagnostics Automated APTT), and the assay per- 
formed according to the manufacturers’ 
instructions. 
2.6. Statistical analysis 
Unpaired Student’s t-test was used to compare 
means for groups of animals. 
3. RESULTS 
Guinea pigs kept on a vitamin C-deficient diet 
and without ascorbic acid supplementation of their 
drinking water all developed symptoms of scurvy 
after 2-3 weeks, whereas control animals kept on 
the same diet but with ascorbic acid added to their 
drinking water showed no evidence of scurvy. The 
symptoms included loss of body weight (fig. l), loss 
of hair, joint swelling and tenderness, petechial 
hemorrhage, and inability or unwillingness to 
stand up. Autopsy showed that all animals in the 
ascorbic acid-deficient group had periarticular 
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Fig.1. Body weight curves for guinea pigs on a vitamin 
C-deficient diet (w), and for guinea pigs on the 
same diet but with vitamin C added to their drinking 
water (M). The body weights are expressed as per 
cent of the weight at the start of the experiment. 
hemorrhages whereas there were no pathological 
findings in the control group. Plasma coagulation, 
as determined by APT-time, did not differ 
significantly between the two groups (p > 0.2). 
Plasma proteins containing y-carboxyglutamic 
acid were isolated by barium citrate adsorption 
and the &hydroxyaspartic acid content was 
determined after acid hydrolysis. Typical chroma- 
tograms for the analysis of fi-hydroxyaspartic acid 
are shown in fig.2. As noted with purified proteins 
[ 1,4], acid hydrolysis causes a partial racemization 
of ,&hydroxyaspartic acid, which explains the ap- 
pearance of some three-P-hydroxyaspartic acid 
eluting at 60 min in the analyzer chromatogram 
(fig.2). There was no significant difference 0, > 
0.2) in &hydroxyaspartic acid content between the 
scorbutic and the control group (table 1). y-Car- 
boxyglutamic acid in the isolated proteins was 
measured after alkaline hydrolysis with &carboxy- 
glutamic acid as an internal standard. On alkaline 
hydrolysis, the P-carboxyglutamic acid gives rise to 
two diastereomeric forms (fig.3). As with the p- 
hydroxyaspartic acid content and that of other 
amino acids (only that of leucine is shown in table 
l), the yield of y-carboxyglutamic acid did not dif- 
fer significantly between the two groups (table 1). 
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Fig.2. Analysis of &hydroxyaspartic acid. (a) Standard 
mixture with 2.0 nmol each of y-carboxyglutamic acid 
(elution time 72 min) and erythro-fl-hydroxyaspartic 
acid (elution time 83 min). (b) Acid hydrolysate of 
barium citrate adsorbed proteins from 1 .O ml of plasma 
from guinea pigs on vitamin C-deficient diet but with 
ascorbic acid in their drinking water (control animals). 
(c) As b, but from guinea pigs without ascorbic acid in 
their drinking water (scorbutic animals). The peak at 
60 min in b and c is threo+hydroxyaspartic acid. y- 
Carboxyglutamic acid was added as an internal standard 
to the samples after hydrolysis [4]. 
Table 1 
Yields of amino acids from barium citrate-adsorbed 
plasma proteins in control and scorbutic guinea pigs 
Control Scorbutic 
animals animals 
No. of animals 5 6 
Yield of amino acids 
(mnol/ml plasma) 
&Hydroxyaspartic acid 2.2* 0.22 2.2* 0.12 
y-Carboxyglutamic acid 30 f 1.2 33 f 2.9 
Leucine 400 k.24 420 k46 
The values, which are the arithmetic means f SE, are 
expressed as nmol amino acid obtained from 1 ml 
plasma with correction for losses according to the 
recovery of ‘251-labeled bovine prothrombin fragment 1. 
&Hydroxyaspartic acid is the sum of the threo and 
erythro forms 
Time (mid 
Fig.3. Analysis of y-carboxyglutamic acid. (a) Alkaline 
hydrolysate of a standard mixture of 5.0 nmol y- 
carboxyglutamic acid and 10.4 nmol fi-carboxyglutamic 
acid. (b) Alkaline hydrolysate of barium citrate 
adsorbed plasma proteins from non-scorbutic animals. 
(c) As b, but from scorbutic animals. In b and c, 
10.4 nmol ,&carboxyglutamic acid was added as an 
internal standard to the sample before hydrolysis. y- 
Carboxyglutamic acid elutes at 73 min and one of the 
two diastereomeric forms of ,&carboxyglutamic acid at 
80 min, the other at 90 min. 
The recoveries of amino acids given in table 1 
were corrected for procedural losses based on the 
recovery of ‘2SI-labeled prothrombin fragment 1, a 
correction open to question since, during the isola- 
tion, fragment 1 does not necessarily behave like 
other plasma proteins that contain y- 
carboxyglutamic acid. However, the yield of frag- 
ment 1 did not vary much between samples (range 
45-72%), nor did a comparison of the uncorrected 
yields show any significant difference between the 
control and scorbutic groups (not shown). 
To evaluate the method used for measuring & 
hydroxyaspartic acid and y-carboxyglutamic acid, 
untreated guinea pigs were compared with animals 
given one large dose of the vitamin K-antagonist, 
warfarin, 24 h previously. In this experiment both 
the @-hydroxyaspartic acid and y-carboxyglutamic 
acid yields were significantly reduced in the 
warfarin-treated animals 0, < 0.0001) (table 2). 
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Table 2 
Yields of amino acids from barium citrate-adsorbed 
plasma proteins in control and warfarin-treated guinea 
pigs 
Control 
animals 
Warfarin- 
treated 
animals 
No. of animals 
Yield of amino acids 
5 5 
(nmol/ml plasma) 
fi-Hydroxyaspartic acid 2.0* 0.12 l.O+ 0.02 
y-Carboxyglutamic a id 35 f 1.2 15 f 0.7 
Leucine 370 *13 340 *24 
The values are expressed as in table 1 
4. DISCUSSION 
Since fl-hydroxyaspartic acid seems only to be 
present in the vitamin K-dependent plasma pro- 
teins, except prothrombin, and at most amounts to 
but a few residues in these proteins [4], its concen- 
tration in plasma is low. A sensitive method based 
on acid hydrolysis followed by cation-exchange 
chromatography at pH 2.0 with fluorimetric detec- 
tion has been designed for measuring /3- 
hydroxyaspartic acid in purified proteins [4]. As 
shown here, this method can be used for analysing 
the crude protein fraction obtained by barium 
citrate adsorption of plasma (fig.2). After base 
hydrolysis of the samples the same chromato- 
graphic system could be used for measuring y-car- 
boxyglutamic acid (fig.3). 
With a sensitive method available for measuring 
&hydroxyaspartic acid in proteins, a possible 
vitamin C-dependency of the post-translational 
hydroxylation of aspartic acid and a hypothesis for 
the explanation of the bleeding in scurvy could be 
tested. If the formation of ,%hydroxyaspartic acid, 
like that of hydroxyproline in collagen, is depen- 
dent on vitamin C, then the bleeding might be 
caused by incompletely hydroxylated, defective 
coagulation factors. The results presented here, 
however, do not support this hypothesis. Despite 
the fact that the guinea pigs in the experimental 
group were all severely scorbutic and had bleeding, 
they all had a normal P-hydroxyaspartic acid con- 
tent in the vitamin K-dependent proteins. The nor- 
mal APT-time in the scorbutic animals also argues 
against the hypothesis that defective humoral 
coagulation factors are a major cause of the 
bleeding in scurvy. 
That the analytical methods used in the scurvy 
experiment were capable of detecting changes in 
the content of protein-bound fl-hydroxyaspartic 
acid was demonstrated by treating guinea pigs with 
the vitamin K-antagonist, warfarin, and subse- 
quently isolating the y-carboxyglutamic acid- 
containing proteins. As expected, the yield of y- 
carboxyglutamic acid decreased, and that of fl- 
hydroxyaspartic acid decreased correspondingly. 
With decreased carboxylation, the amount of 
vitamin K-dependent proteins adsorbed to the 
barium citrate is reduced. Whether the hydroxyla- 
tion of aspartic acid in vitamin K-dependent pro- 
teins is in some way related to the carboxylation 
reaction is not yet known. 
In conclusion, this study has shown that fl- 
hydroxyaspartic acid content can be determined in 
the barium citrate adsorbed plasma protein frac- 
tion, and that this amino acid is not reduced in 
severely scorbutic guinea pigs. Thus the post- 
translational hydroxylation of aspartic acid is 
unlikely to be vitamin C-dependent. 
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